StockNews.AI
MTEX
StockNews.AI
7 days

Mannatech Reports Financial Results for Second Quarter 2025

1. Mannatech's Q2 2025 net sales declined 7.4% from Q2 2024. 2. This decrease may impact investor confidence and stock performance.

Earnings
+14.71%Current Return
VS
+0.35%S&P 500
$8.7108/12 05:35 PM EDTEvent Start
$9.991608/14 12:06 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

The 7.4% decline in sales indicates weakening financial performance, which historically leads to lower stock prices, as seen in similar situations across small-cap health companies that struggled with year-over-year sales decreases.

How important is it?

The decline in sales directly impacts company valuations and investor sentiment, likely leading to a decrease in MTEX's stock price as market participants react to the earnings report.

Why Short Term?

Investor sentiment may decline quickly due to this quarterly decline, affecting MTEX's stock price in the immediate future.

Related Companies

NTRXUSNAHFBG
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2025. Second Quarter Results Net sales for the quarter ended June 30, 2025 were $25.7 million, as compared to $27.7 million for the same period in 2024, a decrease of $2.1 million, or 7.4%. On a Constant dollar basis (see Non-GAAP Measures, b.

Related News